Patents by Inventor Andreas NEERINCX

Andreas NEERINCX has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL SMALL TYPE V RNA PROGRAMMABLE ENDONUCLEASE SYSTEMS
    Publication number: 20250084391
    Abstract: Described herein are novel systems for targeting, editing or manipulating DNA in a cell or cell free environment, using novel type V B-GEn.7 (SEQ ID NO: 1) and variants thereof, as well as methods and kits for manipulating DNA.
    Type: Application
    Filed: December 20, 2022
    Publication date: March 13, 2025
    Applicant: Bayer Aktiengesellschaft
    Inventors: Andre COHNEN, Florian RICHTER, Philipp KNYPHAUSEN, Andreas NEERINCX, Saskia Diana MARKERT, Christien BEDNARSKI, Sören TURAN, Theresa VOGT, Jaishree CHITTOOR
  • NOVEL SMALL RNA PROGRAMMABLE ENDONUCLEASE SYSTEMS WITH IMPOVED PAM SPECIFICITY AND USES THEREOF
    Publication number: 20250051802
    Abstract: Described herein are novel systems for targeting, editing or manipulating DNA in a cell, using novel M-SmallCas9 nucleases and variants thereof. The M-SmallCas9 nucleases are derived from wildtype or parental small type II CRISPR Cas9 endonucleases, and display improved fidelity compared to parental type II CRISPR Cas9 enzymes in combination with a simple PAM sequences and are small endonuclease size.
    Type: Application
    Filed: August 31, 2022
    Publication date: February 13, 2025
    Applicant: Bayer Aktiengesellschaft
    Inventors: Andre COHNEN, Florian RICHTER, Andreas NEERINCX
  • TYPE V RNA PROGRAMMABLE ENDONUCLEASE SYSTEMS
    Publication number: 20240141312
    Abstract: Described herein are novel systems for targeting, editing or manipulating DNA in a cell or cell free environment, using novel type V B-GEn.1 or B-GEn.2 nucleases and variants thereof, as well as methods and kits for manipulating DNA. Further disclosed are novel and improved single guide RNAs.
    Type: Application
    Filed: June 9, 2022
    Publication date: May 2, 2024
    Applicant: Bayer Aktiengesellschaft
    Inventors: Andre COHNEN, Florian RICHTER, Philipp KNYPHAUSEN, Andreas NEERINCX, Saskia Diana MARKERT, Christien BEDNARSKI, Sören TURAN